4.7 Article

CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in &ITMyxococcus xanthus&IT

Journal

MICROBIAL CELL FACTORIES
Volume 17, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s12934-018-0867-1

Keywords

CRISPR/dCas9 activation; sgRNAs; Activator proteins; Promoter; Transcriptional improvement; Biosynthetic gene cluster; Epothilones; Myxococcus xanthus

Funding

  1. NSFC [31370123]
  2. Key Program of Shandong Natural Science Foundation [ZR2016QZ002]
  3. National Natural Science Foundation of China (NSFC) [31471183, 31670076]

Ask authors/readers for more resources

Background: The CRISPR/dCas9 system is a powerful tool to activate the transcription of target genes in eukaryotic or prokaryotic cells, but lacks assays in complex conditions, such as the biosynthesis of secondary metabolites. Results: In this study, to improve the transcription of the heterologously expressed biosynthetic genes for the production of epothilones, we established the CRISPR/dCas9-mediated activation technique in Myxococcus xanthus and analyzed some key factors involving in the CRISPR/dCas9 activation. We firstly optimized the cas9 codon to fit the M. xanthus cells, mutated the gene to inactivate the nuclease activity, and constructed the dCas9-activator system in an epothilone producer. We compared the improvement efficiency of different sgRNAs on the production of epothilones and the expression of the biosynthetic genes. We also compared the improvement effects of different activator proteins, the w and a subunits of RNA polymerase, and the sigma factors sigma 54 and CarQ. By using a copper-inducible promoter, we determined that higher expressions of dCas9-activator improved the activation effects. Conclusions: Our results showed that the CRISPR/dCas-mediated transcription activation is a simple and broadly applicable technique to improve the transcriptional efficiency for the production of secondary metabolites in microorganisms. This is the first time to construct the CRISPR/dCas9 activation system in myxobacteria and the first time to assay the CRISPR/dCas9 activations for the biosynthesis of microbial secondary metabolites.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available